This book is designed to assist physicians in the everyday management of hypertensive patients, with a particular focus on difficult-to-treat and resistant hypertension.
This book establishes and specifies a rigorously scientific and clinically valid basis for nonpharmaceutical approaches to many common diseases and disorders found in clinical settings.
This volume presents one of the clinical foundations of vasculopathies: the biological markers and risk factors associated with cardiovascular disease.
Written by one of the world's most respected cardiologists and designed with the needs of the internist and general clinical cardiologist in mind, this new volume provides clear, accessible guidance on the use of electrocardiography to diagnose and manage cardiovascular disease.
In Medicating Race, Anne Pollock traces the intersecting discourses of race, pharmaceuticals, and heart disease in the United States over the past century, from the founding of cardiology through the FDA's approval of BiDil, the first drug sanctioned for use in a specific race.
Providing a complete but succinct overview of the information cardiologists and cardiology trainees need to have at their fingertips, Practical Cardiovascular Medicine, Second Edition is an everyday primary guide to the specialty.
With an exponential growth in the number of older adults, understanding the common disorders of the elderly patient requiring cardiac care is becoming increasingly important.
Enhancing Fertility through Functional Medicine: Using Nutrigenomics to Solve 'Unexplained' Infertility provides cutting-edge information and solutions to help support the worldwide rise of fertility challenges.
Hundreds of High-Quality Images Span the Entire Spectrum of Vascular DiseaseINCLUDES DVD WITH IMAGE BANKColor Atlas of Vascular Diseases is designed to help you properly identify and manage vascular diseases involving the arterial, venous, and lymphatic system.
Despite a worldwide reduction in its incidence, stroke remains one of the most common diseases generally and the most important cause of premature and persistent disability in the industrialized countries.
La placca ateromasica rappresenta l’elemento patogenetico principale di numerosi processi patologici a carico degli apparati cardiovascolare, cerebrovascolare e nefrovascolare.
This Volume of the series Cardiac and Vascular Biology offers a comprehensive and exciting, state-of-the-art work on the current options and potentials of cardiac regeneration and repair.
Für alle an der herzchirurgischen Intensivmedizin interessierten Leser sind die beiden Kapitel zur postoperativen intensivmedizinischen Betreuung aus der im Jahr 2010 erschienenen 3.
Leading clinicians and researchers concisely review the significant risk factors, including dyslipidemias, hypertension, diabetes, lack of exercise, obesity, tobacco, and homocysteine, and outline the best preventive strategies available.
"e;Cardiovascular Medicine, 3rd edition"e; offers the most up-to-date, user-friendly guidance on the evaluation, diagnosis and medical and surgical treatment of heart and vascular disease and will be relevant to the practice of every cardiologist, cardiac surgeon, vascular surgeon, diabetologist, cardiac radiologist and any physician who manages cardiac patients.
Quality in Laboratory Hemostasis and Thrombosis Second Edition Edited by Steve Kitchen, Clinical Scientist, Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital and Scientific Director, UK National External Quality Assessment Scheme (FQAS) for Blood Coagulation, Scientific Director, WHO and WFH International External Quality Assessment Programs for Blood Coagulation, Sheffield, UK John D Olson, Professor and Vice Chair for Clinical Affairs, Department of Pathology, University of Texas Health Sciences Centre, San Antonio, Texas, USA F.
Given the ever-advancing development of new pharmacological agents to treat heart conditions, clinicians could use a practical report on newly available treatments.
Preface to the Second Edition Despite worldwide efforts to assess and control cardiovascular risk factors, cardiac diseases and in particular coronary artery disease (CAD) are still the foremost causes of death in the developed countries of Western Europe, North America and Asia and are becoming increasingly common in Eastern Europe and the developing world (Deanfield 2001).